Elisabet Granstam

The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden: data from the Swedish Macula Register

Wickman, Isac; Lövestam-Adrian, Monica; Granstam, Elisabet; Kjellström, Ulrika et al.

Ingår i BMC Ophthalmology, 2024

• DOI för The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden: data from the Swedish Macula Register
• Ladda ner fulltext (pdf) av The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden: data from the Swedish Macula Register

Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study

Granstam, Elisabet; Rönnblom, Anders

Ingår i BMJ Open Ophthalmology, 2023

• DOI för Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study
• Ladda ner fulltext (pdf) av Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study

Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

Lundqvist, Martin H.; Patsoukaki, Vagia; Jansson, Stefan P.O.; Norman, Henrietta et al.

Ingår i Diabetes & Vascular Disease Research, 2023

• DOI för Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
• Ladda ner fulltext (pdf) av Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

Cataract surgery in neovascular AMD: impact on visual acuity and disease activity

Tang, Hin Yan; Rosen, Mats; Granstam, Elisabet

Ingår i BMC Ophthalmology, 2023

• DOI för Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
• Ladda ner fulltext (pdf) av Cataract surgery in neovascular AMD: impact on visual acuity and disease activity

Switch of anti-vascular growth factor agent from aflibercept to bevacizumab; outcomes in chronic wet age-related macular degeneration

Granstam, Elisabet; Sjövall, Kersti; Rosen, Mats

Ingår i Acta Ophthalmologica, 2022

• DOI för Switch of anti-vascular growth factor agent from aflibercept to bevacizumab; outcomes in chronic wet age-related macular degeneration

The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden: data from the Swedish Macula Register

Wickman, Isac; Lövestam-Adrian, Monica; Granstam, Elisabet; Kjellström, Ulrika et al.

Ingår i BMC Ophthalmology, 2024

• DOI för The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden: data from the Swedish Macula Register
• Ladda ner fulltext (pdf) av The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden: data from the Swedish Macula Register

Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study

Granstam, Elisabet; Rönnblom, Anders

Ingår i BMJ Open Ophthalmology, 2023

• DOI för Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study
• Ladda ner fulltext (pdf) av Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study

Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

Lundqvist, Martin H.; Patsoukaki, Vagia; Jansson, Stefan P.O.; Norman, Henrietta et al.

Ingår i Diabetes & Vascular Disease Research, 2023

• DOI för Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
• Ladda ner fulltext (pdf) av Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

Cataract surgery in neovascular AMD: impact on visual acuity and disease activity

Tang, Hin Yan; Rosen, Mats; Granstam, Elisabet

Ingår i BMC Ophthalmology, 2023

• DOI för Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
• Ladda ner fulltext (pdf) av Cataract surgery in neovascular AMD: impact on visual acuity and disease activity

Switch of anti-vascular growth factor agent from aflibercept to bevacizumab; outcomes in chronic wet age-related macular degeneration

Granstam, Elisabet; Sjövall, Kersti; Rosen, Mats

Ingår i Acta Ophthalmologica, 2022

• DOI för Switch of anti-vascular growth factor agent from aflibercept to bevacizumab; outcomes in chronic wet age-related macular degeneration

Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting

Granstam, Elisabet; Aurell, Sandra; Sjövall, Kersti; Paul, Anna

Ingår i Graefe's Archives for Clinical and Experimental Ophthalmology, s. 2085-2093, 2021

• DOI för Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
• Ladda ner fulltext (pdf) av Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting

No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study

Granstam, Elisabet; Krifors, Anders; Freyhult, Elisabeth; Akerblom, Hanna

Ingår i BMJ Open Ophthalmology, 2021

• DOI för No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study
• Ladda ner fulltext (pdf) av No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study

Association of Gastric Bypass Surgery With Risk of Developing Diabetic Retinopathy Among Patients With Obesity and Type 2 Diabetes in Sweden: An Observational Study

Akerblom, Hanna; Franzen, Stefan; Zhou, Caddie; Moren, Asa et al.

Ingår i JAMA ophthalmology, s. 200-205, 2021

• DOI för Association of Gastric Bypass Surgery With Risk of Developing Diabetic Retinopathy Among Patients With Obesity and Type 2 Diabetes in Sweden: An Observational Study

Long‐term follow‐up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four‐year real‐world study

Granstam, Elisabet; Rosenblad Karlsson, Andreas; Modher Raghib, Aseel; Granström, Therese et al.

Ingår i Acta Ophthalmologica, s. 360-367, 2020

• DOI för Long‐term follow‐up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four‐year real‐world study

Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration

Aurell, Sandra; Sjövall, Kersti; Paul, Anna; Morén, Åsa et al.

Ingår i Acta Ophthalmologica, s. 519-524, 2019

• DOI för Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration
• Ladda ner fulltext (pdf) av Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration

Response: Debate continues. Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy

Moren, Åsa; Sundbom, Magnus; Ottosson, Johan; Granstam, Elisabet

Ingår i Acta Ophthalmologica, 2019

• DOI för Response: Debate continues. Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy

Patients’ experiences before starting anti-VEGF treatment for sight-threatening diabetic macular oedema: A qualitative interview study

Granström, Therese; Forsman, Henrietta; Brorsson, Anna-Lena; Granstam, Elisabet et al.

Ingår i Nordic journal of nursing research, s. 11-17, 2018

• DOI för Patients’ experiences before starting anti-VEGF treatment for sight-threatening diabetic macular oedema: A qualitative interview study

Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy

Morén, Åsa; Sundbom, Magnus; Ottosson, Johan; Granstam, Elisabet

Ingår i Acta Ophthalmologica, s. 279-282, 2018

• DOI för Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy

Seven years treatment outcome of neovascular age-related macula degeneration. Data from the Swedish Macula Register.

Westborg, Inger; Granstam, Elisabet; Albrecht, Susanne; Rosso, Aldana et al.

Ingår i Investigative Ophthalmology and Visual Science, 2017

Treatment for neovascular age-related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register

Westborg, Inger; Granstam, Elisabet; Rosso, Aldana; Albrecht, Susanne et al.

Ingår i Acta Ophthalmologica, s. 787-795, 2017

• DOI för Treatment for neovascular age-related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register

Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

Granström, Therese; Forsman, Henrietta; Olinder, Anna Lindholm; Gkretsis, Dimitrios et al.

Ingår i Diabetes Research and Clinical Practice, s. 157-165, 2016

• DOI för Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting
• Ladda ner fulltext (pdf) av Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

Patient reported outcomes and visual function among patients with diabetes related macular edema

Granström, Therese; Forsman, Henrietta; Leksell, Janeth; Granstam, Elisabet

Ingår i Quality of Life Research, s. 130-131, 2016

Reduced occurrence of severe visual impairment after introduction of anti-Vascular Endothelial Growth Factor in wet age-related macular degeneration: a population- and register-based study from northern Sweden

Granstam, Elisabet; Westborg, Inger; Barkander, Anna; Börjesson, Malin et al.

Ingår i Acta Ophthalmologica, s. 646-651, 2016

• DOI för Reduced occurrence of severe visual impairment after introduction of anti-Vascular Endothelial Growth Factor in wet age-related macular degeneration: a population- and register-based study from northern Sweden

Bacterial keratitis in a Swedish county hospital: management and clinical outcome

Aurell, Sandra; Granstam, Elisabet

Ingår i Acta Ophthalmologica, 2016

• DOI för Bacterial keratitis in a Swedish county hospital: management and clinical outcome

Anti VEGF-treatment for wet-AMD According to a Treat-and-Extend Protocol at a Swedish County Hospital: clinical outcomes at 12 Months

Granstam, Elisabet; Sjovall, Kersti; Paul, Anna; Moren, Asa

Ingår i Investigative Ophthalmology and Visual Science, 2016

Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema

Granström, Therese; Forsman, Henrietta; Leksell, Janeth; Jani, Siba et al.

Ingår i Journal of diabetes and its complications, s. 1183-1190, 2015

• DOI för Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema
• Ladda ner fulltext (pdf) av Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema

Change of treatment strategy for wet AMD from PRN to Treat-and-Extend: 6 months experience from a Swedish county hospital

Granstam, Elisabet; Sjovall, Kersti; Paul, Anna; Eriksson, Laila

Ingår i Investigative Ophthalmology and Visual Science, 2015

Comparison of peroperative subconjunctival injection of methylprednisolone and standard postoperative steroid drops after uneventful cataract surgery

Merkoudis, Nikolaos; Matsson, Anna Wikberg; Granstam, Elisabet

Ingår i Acta Ophthalmologica, s. 623-628, 2014

• DOI för Comparison of peroperative subconjunctival injection of methylprednisolone and standard postoperative steroid drops after uneventful cataract surgery

Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting

Merkoudis, Nikolaos; Granstam, Elisabet

Ingår i European Journal of Ophthalmology, s. 558-563, 2013

• DOI för Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting

Treatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye: a case report

Merkoudis, Nikolaos; Granstam, Elisabet

Ingår i Acta Ophthalmologica, 2013

• DOI för Treatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye: a case report

Acute retinal pigment epitheliitis: optical coherence tomography findings at onset and follow-up

Merkoudis, Nikolaos; Granstam, Elisabet

Ingår i Acta Ophthalmologica, 2013

• DOI för Acute retinal pigment epitheliitis: optical coherence tomography findings at onset and follow-up

Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls

Eriksson, Urban; Alm, Albert; Bjärnhall, Gunilla; Granstam, Elisabet et al.

Ingår i Graefe's Archives for Clinical and Experimental Ophthalmology, s. 349-359, 2011

• DOI för Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls

Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: relation to nitric oxide synthase and cyclooxygenase inhibition

Granstam, Sven-Olof; Granstam, Elisabet

Ingår i Journal of Physiological Sciences, s. 497-505, 2011

• DOI för Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: relation to nitric oxide synthase and cyclooxygenase inhibition